HK1208223A1 - 1,2,4-triazine derivatives for the treatment of viral infections 124- - Google Patents
1,2,4-triazine derivatives for the treatment of viral infections 124-Info
- Publication number
- HK1208223A1 HK1208223A1 HK15108914.9A HK15108914A HK1208223A1 HK 1208223 A1 HK1208223 A1 HK 1208223A1 HK 15108914 A HK15108914 A HK 15108914A HK 1208223 A1 HK1208223 A1 HK 1208223A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- treatment
- viral infections
- triazine derivatives
- triazine
- derivatives
- Prior art date
Links
- 150000003920 1,2,4-triazines Chemical class 0.000 title 1
- 208000036142 Viral infection Diseases 0.000 title 1
- 230000009385 viral infection Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D253/075—Two hetero atoms, in positions 3 and 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Epidemiology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12306196.2A EP2712866A1 (fr) | 2012-10-01 | 2012-10-01 | Dérivés de 1,2,4-triazine pour le traitement d'infections virales |
| PCT/EP2013/070488 WO2014053516A1 (fr) | 2012-10-01 | 2013-10-01 | Dérivés 1,2,4-triazines pour le traitement d'infections virales |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1208223A1 true HK1208223A1 (en) | 2016-02-26 |
Family
ID=46982496
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK15108914.9A HK1208223A1 (en) | 2012-10-01 | 2015-09-11 | 1,2,4-triazine derivatives for the treatment of viral infections 124- |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US9416114B2 (fr) |
| EP (2) | EP2712866A1 (fr) |
| JP (1) | JP6298998B2 (fr) |
| KR (1) | KR102138393B1 (fr) |
| CN (1) | CN104812747B (fr) |
| AU (1) | AU2013326579B2 (fr) |
| BR (1) | BR112015007310B1 (fr) |
| CA (1) | CA2886630C (fr) |
| CL (1) | CL2015000787A1 (fr) |
| EA (1) | EA026236B1 (fr) |
| ES (1) | ES2616496T3 (fr) |
| HK (1) | HK1208223A1 (fr) |
| IL (1) | IL237871A (fr) |
| IN (1) | IN2015DN03327A (fr) |
| MX (1) | MX348229B (fr) |
| MY (1) | MY182558A (fr) |
| NZ (1) | NZ706354A (fr) |
| PH (1) | PH12015500724B1 (fr) |
| SG (1) | SG11201502522WA (fr) |
| UA (1) | UA114644C2 (fr) |
| WO (1) | WO2014053516A1 (fr) |
| ZA (1) | ZA201502240B (fr) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9422250B2 (en) | 2011-04-08 | 2016-08-23 | Janssen Sciences Ireland Uc | Pyrimidine derivatives for the treatment of viral infections |
| PT2776439T (pt) | 2011-11-09 | 2018-11-02 | Janssen Sciences Ireland Uc | Derivados de purina para o tratamento de infeções virais |
| AU2013288600B2 (en) | 2012-07-13 | 2017-06-29 | Janssen Sciences Ireland Uc | Macrocyclic purines for the treatment of viral infections |
| KR102217111B1 (ko) | 2012-10-10 | 2021-02-18 | 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 | 바이러스 감염 및 다른 질환 치료를 위한 피롤로[3,2-d]피리미딘 유도체 |
| NZ706226A (en) | 2012-11-16 | 2019-09-27 | Janssen Sciences Ireland Uc | Heterocyclic substituted 2-amino-quinazoline derivatives for the treatment of viral infections |
| EP2958900B1 (fr) | 2013-02-21 | 2019-04-10 | Janssen Sciences Ireland Unlimited Company | Dérivés de 2-aminopyrimidine pour le traitement d'infections virales |
| EA202090547A3 (ru) | 2013-03-29 | 2020-12-30 | Янссен Сайенсиз Айрлэнд Юси | Макроциклические деаза-оксипурины для лечения вирусных инфекций |
| ES2657283T3 (es) | 2013-05-24 | 2018-03-02 | Janssen Sciences Ireland Uc | Derivados de piridona para el tratamiento de infecciones virales y enfermedades adicionales |
| SG10201803331PA (en) | 2013-06-27 | 2018-06-28 | Janssen Sciences Ireland Uc | Pyrrolo[3,2-d]pyrimidine derivatives for the treatment of viral infections and other diseases |
| BR112016001570B1 (pt) | 2013-07-30 | 2020-12-15 | Janssen Sciences Ireland Uc | Derivados de tieno[3,2-d]pirimidinas e composição farmacêutica que os compreende para o tratamento de infecções virais |
| SG11201811448RA (en) | 2016-07-01 | 2019-01-30 | Janssen Sciences Ireland Unlimited Co | Dihydropyranopyrimidines for the treatment of viral infections |
| AU2017335205B2 (en) * | 2016-09-29 | 2021-11-04 | Janssen Sciences Ireland Unlimited Company | Pyrimidine prodrugs for the treatment of viral infections and further diseases |
| TW201945003A (zh) | 2018-03-01 | 2019-12-01 | 愛爾蘭商健生科學愛爾蘭無限公司 | ２，４－二胺基喹唑啉衍生物及其醫學用途 |
| JP7287708B2 (ja) | 2019-02-08 | 2023-06-06 | プロジェニア インコーポレイテッド | Ｔｏｌｌ－ｌｉｋｅ受容体７または８アゴニストとコレステロールの結合体およびその用途 |
| WO2021177679A1 (fr) | 2020-03-02 | 2021-09-10 | 성균관대학교산학협력단 | Nanoparticules mimétiques d'agent pathogène vivant basées sur un squelette de paroi cellulaire d'agent pathogène, et leur procédé de production |
| US20230346924A1 (en) | 2020-08-04 | 2023-11-02 | Progeneer Inc. | Mrna vaccine comprising adjuvant capable of kinetic control |
| JP2023536954A (ja) | 2020-08-04 | 2023-08-30 | プロジェニア インコーポレイテッド | 活性化部位が一時的に不活性化したトール様受容体７または８作用薬と機能性薬物の結合体およびその用途 |
| US20230355750A1 (en) | 2020-08-04 | 2023-11-09 | Progeneer Inc. | Kinetically acting adjuvant ensemble |
| WO2024151953A1 (fr) * | 2023-01-15 | 2024-07-18 | Viradem Inc. | Composés et méthodes destinés au traitement de maladies causées par le sars-cov-2 et d'autres coronavirus |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2485531A1 (fr) * | 1980-06-25 | 1981-12-31 | Fabre Sa Pierre | Nouveaux n-oxydes de diaryl-5,6 as triazines 1-2-4, leur application a titre de medicaments et les compositions pharmaceutiques les contenant |
| AU698419B2 (en) | 1996-07-03 | 1998-10-29 | Dainippon Sumitomo Pharma Co., Ltd. | A novel purine derivative |
| CA2311742C (fr) | 1997-11-28 | 2009-06-16 | Sumitomo Pharmaceuticals Co., Ltd. | Nouveaux composes heterocycliques |
| AU2005271161B2 (en) * | 2004-08-10 | 2011-05-12 | Janssen Pharmaceutica N.V. | HIV inhibiting 1,2,4-triazin-6-one derivatives |
| EA200702235A1 (ru) | 2005-05-04 | 2008-04-28 | Пфайзер Лимитед | Производные 2-амидо-6-амино-8-оксопурина в качестве модуляторов toll-подобных рецепторов для лечения рака и вирусных инфекций, таких как гепатит с |
| CN101296907B (zh) * | 2005-09-01 | 2013-03-27 | 弗·哈夫曼-拉罗切有限公司 | 作为p2x3和p2x2/3调节剂的二氨基嘧啶类 |
| RU2352565C1 (ru) * | 2007-10-08 | 2009-04-20 | Государственное образовательное учреждение высшего профессионального образования "Пермский государственный университет" | 3-амино-6-ароилметил-5-гидрокси-1,2,4-триазины и способ их получения |
| PE20091236A1 (es) * | 2007-11-22 | 2009-09-16 | Astrazeneca Ab | Derivados de pirimidina como immunomoduladores de tlr7 |
| WO2012067269A1 (fr) * | 2010-11-19 | 2012-05-24 | Dainippon Sumitomo Pharma Co., Ltd. | Composés aminoalcoxyphényle et leur utilisation dans le traitement de maladies |
-
2012
- 2012-10-01 EP EP12306196.2A patent/EP2712866A1/fr not_active Withdrawn
-
2013
- 2013-10-01 EA EA201500383A patent/EA026236B1/ru not_active IP Right Cessation
- 2013-10-01 IN IN3327DEN2015 patent/IN2015DN03327A/en unknown
- 2013-10-01 MY MYPI2015000804A patent/MY182558A/en unknown
- 2013-10-01 SG SG11201502522WA patent/SG11201502522WA/en unknown
- 2013-10-01 CA CA2886630A patent/CA2886630C/fr active Active
- 2013-10-01 AU AU2013326579A patent/AU2013326579B2/en active Active
- 2013-10-01 EP EP13773690.6A patent/EP2903976B1/fr active Active
- 2013-10-01 MX MX2015004160A patent/MX348229B/es active IP Right Grant
- 2013-10-01 UA UAA201504222A patent/UA114644C2/uk unknown
- 2013-10-01 US US14/432,269 patent/US9416114B2/en active Active
- 2013-10-01 NZ NZ706354A patent/NZ706354A/en not_active IP Right Cessation
- 2013-10-01 BR BR112015007310-7A patent/BR112015007310B1/pt not_active IP Right Cessation
- 2013-10-01 WO PCT/EP2013/070488 patent/WO2014053516A1/fr active Application Filing
- 2013-10-01 ES ES13773690.6T patent/ES2616496T3/es active Active
- 2013-10-01 KR KR1020157009515A patent/KR102138393B1/ko active IP Right Grant
- 2013-10-01 JP JP2015533635A patent/JP6298998B2/ja active Active
- 2013-10-01 CN CN201380050972.5A patent/CN104812747B/zh active Active
-
2015
- 2015-03-22 IL IL237871A patent/IL237871A/en active IP Right Grant
- 2015-03-30 CL CL2015000787A patent/CL2015000787A1/es unknown
- 2015-03-31 ZA ZA2015/02240A patent/ZA201502240B/en unknown
- 2015-03-31 PH PH12015500724A patent/PH12015500724B1/en unknown
- 2015-09-11 HK HK15108914.9A patent/HK1208223A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1208223A1 (en) | 1,2,4-triazine derivatives for the treatment of viral infections 124- | |
| HK1256490A1 (zh) | 用於治療病毒感染的嘧啶衍生物 | |
| ZA201405820B (en) | Piperidino-pyrimidine derivatives for the treatment of viral infections | |
| HK1211589A1 (en) | Compounds for the treatment of paramoxyvirus viral infections | |
| ZA201603123B (en) | Pyrrolo [1,2,f] [1,2,4] triazines useful for treating respiratory syncitial virus infections | |
| HK1213569A1 (zh) | 用於治療病毒性感染的 -氨基嘧啶衍生物 | |
| ZA201500921B (en) | Alkylpyrimidine derivatives for the treatment of viral infections and further diaseases | |
| SG11201503042QA (en) | Heterocyclic substituted 2-amino-quinazoline derivatives for the treatment of viral infections | |
| IL240765A0 (en) | Macrocyclic daza-furanones for the treatment of viral infections | |
| ZA201306342B (en) | The treatment of viral infections | |
| TH1501001789A (th) | อนุพันธ์ของ 1,2,4-ไตรอะซีน สำหรับการบำบัดของโรคติดเชื้อไวรัส |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20231001 |